China’s pharmaceutical industry: from manufacturing hub to key R&D player
Since joining the World Trade Organization in 2001, China’s pharmaceutical industry has experienced remarkable growth. In 2021, it accounted for 12% of the global pharmaceutical market, second only to the United States, which accounted for a substantial 40% of the world’s total revenue. By 2022, despite challenges from the COVID-19 pandemic, the industry demonstrated resilience, […]
With increased government intervention and sector growth, the OTC Healthcare Market in China continues to grow
How will the OTC Healthcare Market in China fare amidst growing pains? Daxue Consulting has helped many clients in the health services industry navigate the myriad of challenges that the Chinese market holds. Through our work, we have developed our expert insights on the many intricacies of the Chinese market’s […]